- Význam imunogenní buněčné smrti v protinádorové imunitě2015 | 2. lékařská fakulta
- Detection of immunogenic cell death and its relevance for cancer therapy2020 | 2. lékařská fakulta
- Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death2020 | 2. lékařská fakulta
- Trial watch: chemotherapy-induced immunogenic cell death in oncology2023 | 2. lékařská fakulta
- Prognostický a prediktivní význam kalretikulinu, klíčové molekuly imunogenní buněčné smrti v biologii nádorových onemocnění2019 | 2. lékařská fakulta
- High hydrostatic pressure induces immunogenic cell death in human tumor cells2014 | 2. lékařská fakulta
- Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells2017 | 2. lékařská fakulta
- Combinatorial strategies for the induction of immunogenic cell death2015 | 2. lékařská fakulta
- Consensus guidelines for the detection of immunogenic cell death2014 | 2. lékařská fakulta
- Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death2015 | 2. lékařská fakulta
- Consensus guidelines for the definition, detection and interpretation of immunogenic cell death2020 | 2. lékařská fakulta
- Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy2015 | 2. lékařská fakulta
- Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology2020 | 2. lékařská fakulta
- STING agonist-induced cytokine production with anti-HBV activity is accompanied by immunogenic cell death of monocytesPublikace bez příslušnosti k fakultě
- Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer2018 | 2. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death2017 | 2. lékařská fakulta
- Radiotherapy in Combination With Cytokine Treatment2019 | 2. lékařská fakulta
- Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial2021 | 1. lékařská fakulta, 3. lékařská fakulta, Ústřední knihovna
- Type I interferon and cancer2024 | 2. lékařská fakulta
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications2016 | 2. lékařská fakulta
- Chapter Three - Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents2017 | 2. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients2019 | 2. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové, Lékařská fakulta v Plzni
- Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents2022 | 2. lékařská fakulta, 1. lékařská fakulta, 3. lékařská fakulta
- Calreticulin arms NK cells against leukemia2020 | 2. lékařská fakulta
- Trial watch: Dendritic cell-based anticancer therapy2014 | 2. lékařská fakulta
- Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy2014 | 2. lékařská fakulta
- Trial Watch Dendritic cell-based interventions for cancer therapy2013 | 2. lékařská fakulta
- Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response2011 | 2. lékařská fakulta, 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
- Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy2016 | 2. lékařská fakulta
- Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer2015 | 2. lékařská fakulta